SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cancer Genetics Q3 Sales $2.07M Up From $535K YoY

Cancer Genetics (NASDAQ:CGIX) reported $2.07 million in sales this quarter. This is a 286.92 percent increase over sales of $535 thousand the same period last year.

Benzinga · -

Cancer Genetics (NASDAQ:CGIX) reported $2.07 million in sales this quarter. This is a 286.92 percent increase over sales of $535 thousand the same period last year.